Path B Enhancement of NM Department of Agriculture's Produce Safety Program.

项目摘要 这一资金机会为加强国家生产安全计划提供了条件，以 确保新鲜水果和蔬菜的安全生产，并强制遵守 美国食品和药物管理局条例“生长、收获、包装和 持有供人食用的产品“(称为”生产安全规则“)。而当 许多州可能没有足够的资源，没有足够的资源参与和资助 这一赠款机会提供了实施和维护可行的、一致的 有助于减少食源性疾病、微生物危害的监管计划 以及一个全国性的综合食品安全体系。新墨西哥州农业部 (NMDA)有资格申请本合作协议，路径B。 在这份为期五年的合作协议中，NMDA将与FDA合作 继续念那句口头禅：“在监管之前和在监管的同时进行教育”。NMDA将进一步 发展我们的基础设施和能力，以便在新墨西哥州实施生产安全计划。 这些方案的重点将继续是为种植者提供教育、宣传和技术援助。 以及监管者。核查和制定农场清查方案将继续 主要关注增强计划与FDA共享有意义数据的能力 和其他司法管辖区。NMDA还将继续开发和完善一种监管产品 FDA授权的安全检查、合规和执行计划， FDA的满意度。

PROJECT ABSTRACT This Funding Opportunity provides for the enhancement of the State Produce Safety Programs to ensure the safe production of fresh fruits and vegetables and to enforce compliance with the requirements of FDA's Regulation “Standards for the Growing, Harvesting, Packing, and Holding of Produce for Human Consumption” (referred to as the Produce Safety Rule). While many states may not have sufficient resources on their own, participation in and funding through this grant opportunity provides the resources to implement and maintain a viable, aligned regulatory program contributing to a reduction of foodborne illnesses, microbiological hazards and a nationally integrated food safety system. The New Mexico Department of Agriculture (NMDA) is eligible to apply for this Cooperative Agreement, Path B. Over the course of this five-year cooperative agreement, the NMDA will work with the FDA continuing with the mantra “educate before and while you regulate”. The NMDA will further develop our infrastructure and capacity to operate a Produce Safety Program in New Mexico. The programs focus will continue with education, outreach and technical assistance for growers and regulators. Verification and development of the programs farm inventory will continue to main focus while enhancing the programs capabilities to share meaningful data with the FDA and other jurisdictions. NMDA will also continue to develop and refine a regulatory Produce Safety Inspection, Compliance and Enforcement Program under FDA authority, to the satisfaction of FDA.